Vaxxa AB Statistics

Total Valuation

Vaxxa AB has a market cap or net worth of SEK 39.64 million. The enterprise value is 28.56 million.

Market Cap	39.64M
Enterprise Value	28.56M

Important Dates

The next estimated earnings date is Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Vaxxa AB has 43.37 million shares outstanding. The number of shares has increased by 37.17% in one year.

Current Share Class	43.37M
Shares Outstanding	43.37M
Shares Change (YoY)	+37.17%
Shares Change (QoQ)	+14.71%
Owned by Insiders (%)	3.48%
Owned by Institutions (%)	n/a
Float	41.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.55
PB Ratio	1.67
P/TBV Ratio	2.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-47.12
EV / Sales	0.40
EV / EBITDA	21.49
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.03.

Current Ratio	1.96
Quick Ratio	1.92
Debt / Equity	0.03
Debt / EBITDA	0.55
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -3.42% and return on invested capital (ROIC) is -2.41%.

Return on Equity (ROE)	-3.42%
Return on Assets (ROA)	-1.64%
Return on Invested Capital (ROIC)	-2.41%
Return on Capital Employed (ROCE)	-3.01%
Revenue Per Employee	10.21M
Profits Per Employee	-86,571
Employee Count	8
Asset Turnover	2.60
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.42% in the last 52 weeks. The beta is 0.36, so Vaxxa AB's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	+36.42%
50-Day Moving Average	0.91
200-Day Moving Average	1.17
Relative Strength Index (RSI)	43.80
Average Volume (20 Days)	23,743

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vaxxa AB had revenue of SEK 71.44 million and -606,000 in losses. Loss per share was -0.01.

Revenue	71.44M
Gross Profit	205,000
Operating Income	-723,000
Pretax Income	-606,000
Net Income	-606,000
EBITDA	1.33M
EBIT	-723,000
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 11.81 million in cash and 726,000 in debt, giving a net cash position of 11.08 million or 0.26 per share.

Cash & Cash Equivalents	11.81M
Total Debt	726,000
Net Cash	11.08M
Net Cash Per Share	0.26
Equity (Book Value)	23.68M
Book Value Per Share	0.55
Working Capital	12.17M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.57M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 0.29%, with operating and profit margins of -1.01% and -0.85%.

Gross Margin	0.29%
Operating Margin	-1.01%
Pretax Margin	-0.85%
Profit Margin	-0.85%
EBITDA Margin	1.86%
EBIT Margin	-1.01%
FCF Margin	n/a

Dividends & Yields

Vaxxa AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.17%
Shareholder Yield	n/a
Earnings Yield	-1.53%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 14, 2024. It was a reverse split with a ratio of 0.01.

Last Split Date	Mar 14, 2024
Split Type	Reverse
Split Ratio	0.01

Scores

Vaxxa AB has an Altman Z-Score of 4.98 and a Piotroski F-Score of 2.

Altman Z-Score	4.98
Piotroski F-Score	2